| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070093411 Diabetic inhalant formulation including surfactant and optionally preservative, isotonicizing agent, buffer and/or excipient |
| 04/26/2007 | US20070092910 Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases |
| 04/26/2007 | US20070092567 Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
| 04/26/2007 | US20070092551 Therapeutic agent |
| 04/26/2007 | DE102005049953A1 Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen Carbamoylbenzotriazol derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2626461A1 Compositions for lowering serum cholesterol and/or triglycerides |
| 04/26/2007 | CA2626441A1 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | CA2626422A1 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 04/26/2007 | CA2625783A1 A1 adenosine receptor agonists |
| 04/26/2007 | CA2625722A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2625442A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2625416A1 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 04/26/2007 | CA2624931A1 Therapeutic agent |
| 04/26/2007 | CA2624532A1 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 04/26/2007 | CA2624007A1 Acyl indoles, compositions containing such compounds and methods of use |
| 04/25/2007 | EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776956A1 Preventive and/or therapeutic agent for calcipenia |
| 04/25/2007 | EP1776955A1 Method and composition for the treatment of lipid and glucose metabolism disorders |
| 04/25/2007 | EP1776954A2 The use of inhibitors of the renin-angiotensin system for the treatment of stroke |
| 04/25/2007 | EP1776953A1 Solid oral dosage forms comprising valsartan |
| 04/25/2007 | EP1776366A1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 04/25/2007 | EP1776338A1 Indole, indazole or indoline derivatives |
| 04/25/2007 | EP1776102A1 Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation |
| 04/25/2007 | EP1776098A1 Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypogonadism, elevated triglycerides and high cholesterol |
| 04/25/2007 | EP1520003B1 Process for recovery of plant sterols from by-product of vegetable oil refining |
| 04/25/2007 | EP1392335B1 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1100780B1 2,3,3a,4,9,9a-HEXAHYDRO-8-HYDROXY-1H-BENZ[F]INDOLES, A METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS |
| 04/25/2007 | EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 04/25/2007 | CN1953763A Y4 selective receptor agonists for therapeutic interventions |
| 04/25/2007 | CN1953756A Insulin resistance improving agent |
| 04/25/2007 | CN1953670A Composition, use of a composition and a method for treating obesity |
| 04/25/2007 | CN1952116A Bacillusamyloliquefaciens strain and application thereof |
| 04/25/2007 | CN1951965A Glp－1衍生物 Glp-1 derivatives |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951917A Pyridinone derivatives for treatment of atherosclerosis |
| 04/25/2007 | CN1951480A Medicament for treating type 2 diabetes |
| 04/25/2007 | CN1951457A Chinese medicinal preparation for treating proteinuria caused by diabetic nephropathy and preparation method thereof |
| 04/25/2007 | CN1951402A Method for preparing active polypeptide and zinc protein of sea cucumber |
| 04/25/2007 | CN1951399A A refined fur seal enriched in OMEGA-3 polyunsaturated fatty acid and preparation thereof |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951372A Solid oral dosage forms comprising valsartan and HCTZ |
| 04/25/2007 | CN1951370A Method for preparing solid dispersible minipills of Simvastatin |
| 04/25/2007 | CN1951238A Diet drink |
| 04/25/2007 | CN1951230A Calcium carbonate powder composition and its preparation method |
| 04/25/2007 | CN1951228A A replenishing drink |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312178C High density lipoprotein-reactive peptides |
| 04/25/2007 | CN1312165C Aryl 5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same |
| 04/25/2007 | CN1312154C Purine derivatives as kinase inhibitors |
| 04/25/2007 | CN1312152C New purine derivatives |
| 04/25/2007 | CN1312140C Lipid lowering biphenylcarboxamides |
| 04/25/2007 | CN1312139C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 04/25/2007 | CN1312121C Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1312116C Calcium acceptor active compound |
| 04/25/2007 | CN1312089C Eudesmane compounds, preparing method and use in preparing medicinal composition |
| 04/25/2007 | CN1311868C Preparing process of insulin powder inhalant |
| 04/25/2007 | CN1311865C Prolonged delivery of peptides |
| 04/25/2007 | CN1311853C Quick release Yuquan micropill |
| 04/25/2007 | CN1311852C Yuquan extractum and its medicine composition and use |
| 04/25/2007 | CN1311839C Nano-level pearl powder-conch powder biological calcium tablet |
| 04/25/2007 | CN1311836C Functional chewing gum composition for improving effectively obesity and blood fat |
| 04/25/2007 | CN1311835C Pharmaceutical parenteral composition containing biphosphonate |
| 04/25/2007 | CN1311825C Pioglitazone soft capsule and its preparing method |
| 04/24/2007 | USRE39585 Administering streptococcus thermophilus in admixture withLactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum or Bifidobacterium breve |
| 04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 04/24/2007 | US7208596 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 04/24/2007 | US7208594 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds, |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208522 Methods and compositions for the prevention and treatment of Syndrome X |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208486 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 04/24/2007 | US7208297 Nucleotide sequence encoding a polypeptide derived from fungus Thraustochytrium aureum; expression of vector results in production of polyunsaturated fatty acid (omega 6-docosapentaenoic acid and docosahexaenoic acid); use in pharmaceutical compositions, animal feeds and cosmetics |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208178 For facilitating the delivery of active agents, such as insulin, to a target |
| 04/24/2007 | CA2410852C 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinic receptor antagonists |
| 04/24/2007 | CA2407763C Para-amine substituted phenylamide glucokinase activators |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2289574C 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/24/2007 | CA2268741C Uses of keratinocyte growth factor-2 |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic |
| 04/24/2007 | CA2159776C Imidobisphosphoric acids, process for their preparation, and use thereof |
| 04/19/2007 | WO2007044580A1 Methods for reducing weight |
| 04/19/2007 | WO2007044560A2 Modulators of atp-binding cassette transporters |
| 04/19/2007 | WO2007044547A1 Methods for achieving and maintaining weight loss |
| 04/19/2007 | WO2007044215A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 04/19/2007 | WO2007043933A1 Probiotics to influence fat metabolism and obesity |
| 04/19/2007 | WO2007043870A1 Leucine rich composition |
| 04/19/2007 | WO2007043853A1 Pharmaceutical compositions comprising combined antidiabetic substances for use in diabetes mellitus |